Oxford University and AstraZeneca have acknowledged a manufacturing error meant some trial participants received only a partial dose of their experimental Covid-19 vaccine.The announcement has raised questions about why researchers did not mention the error when they claimed the jab was “highly effective” just days ago.HuffPost is now a part of Verizon Media